Ala Zeyad Jamal, MD in Sacramento, CA - Medicare Student in an Organized Health Care Education/Training Program

Ala Zeyad Jamal, MD is a medicare enrolled "Student In An Organized Health Care Education/training Program" in Sacramento, California. His current practice location is 4150 V Street, Pssb 1200, Sacramento, California. You can reach out to his office (for appointments etc.) via phone at (916) 734-5028.

Ala Zeyad Jamal is licensed to practice in California (license number PTL7031) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1033528385.

Contact Information

	Ala Zeyad Jamal, MD
	4150 V Street, Pssb 1200, Sacramento, CA 95817-1418
	(916) 734-5028
	Not Available

Provider's Profile

Full Name	Ala Zeyad Jamal
Gender	Male
Speciality	Student In An Organized Health Care Education/training Program
Location	4150 V Street, Sacramento, California
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1033528385
Provider Enumeration Date: 08/11/2014
Last Update Date: 12/11/2021

Medicare PECOS Information:

PECOS PAC ID: 3476774415
Enrollment ID: I20141016001383

Medical Identifiers

Medical identifiers for Ala Zeyad Jamal such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1033528385	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
363AM0700X	Physician Assistant - Medical	PA51817 (California)	Secondary
363AS0400X	Physician Assistant - Surgical	PA51817 (California)	Secondary
390200000X	Student In An Organized Health Care Education/training Program	PTL7031 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ala Zeyad Jamal is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Ala Zeyad Jamal, MD 4150 V Street, Pssb 1200, Sacramento, CA 95817-1418 Ph: (916) 734-5028	Ala Zeyad Jamal, MD 4150 V Street, Pssb 1200, Sacramento, CA 95817-1418 Ph: (916) 734-5028

News Archive

Superbugs and antibiotic resistance

Health experts come together today (Thursday) to warn that a new form of superbug that gives bacteria the power to resist virtually all known antibiotics is spreading quickly, posing a global health disaster. It is called New Delhi metallobeta-lactamase, or NDM-1 for short. This enzyme destroys carbapenems, an important group of antibiotics used for difficult infections in hospitals, and has been found in a wide variety of bacterial types. British researchers last August reported that infections involving NDM-1 had been found in patients in Bangladesh, India, Pakistan and Britain.

Protein complex may be an effective alternative to opioid pain medications

A drug targeting a protein complex containing two different types of opioid receptors may be an effective alternative to morphine and other opioid pain medications, without any of the side effects or risk of dependence, according to research led by the Icahn School of Medicine at Mount Sinai.

Aortic stenosis doubles in patients with family history of the condition

Aortic stenosis is the most common heart valve disease in the elderly. It is associated with congenital bicuspid aortic valve and previous rheumatic heart disease, but is also often caused by calcification of a normal valve. Calcification of a normal valve may be associated with atherosclerotic changes in the portion of the aorta closest to the valve.

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

For nearly 60 years, Pyrazinamide (PZA) has been used in conjunction with other medications to treat tuberculosis (TB), but scientists did not fully understand how the drug killed TB bacteria. PZA plays a unique role in shortening the duration of current TB therapy to six months and is used frequently to treat multi-drug resistant TB.

Hearing loss, high blood sugar linked to poor cognitive performance among older Latinos

Hearing loss and diabetes are major public health problems, with Latinos at higher risk than other demographic groups.

Ala Zeyad Jamal, MD - Medicare Student in an Organized Health Care Education/Training Program in Sacramento, CA